Association of poorly controlled HbA(1c) with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease

Glycosylated hemoglobin (HbA1c) targets for patients with chronic kidney disease (CKD) and type 2 diabetes remain controversial. To evaluate whether baseline HbA(1c) and HbA(1c) trajectories are associated with the risk of end-stage kidney disease (ESKD) and all-cause mortality, we recruited adult p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sheng-Jen, Chiang, Hsiu-Yin, Chen, Pei-Shan, Chang, Shih-Ni, Chen, Sheng-Hsuan, Wu, Min-Yen, Yeh, Hung-Chieh, Ting, I-Wen, Tsai, Hsiu-Chen, Chen, Pei-Chun, Kuo, Chin-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512200/
https://www.ncbi.nlm.nih.gov/pubmed/36155491
http://dx.doi.org/10.1371/journal.pone.0274605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512200/
https://www.ncbi.nlm.nih.gov/pubmed/36155491
http://dx.doi.org/10.1371/journal.pone.0274605

Ejemplares similares